Dean Manson

CLO Dean Manson sold 10,000 shares at $130.39 via scheduled 10b5-1 plan; retains 5,058 non-derivative shares plus 61,700 options.

Dean Manson, Chief Legal Officer, executed 2 separate sales totaling 10,000 shares for $1,303,900.00 on 2026-06-12, part of a pre-arranged 10b5-1 trading plan adopted on 2026-03-05. The transactions occurred at $130.39 per share, while the current price stands at $120.97, representing a decline of -17.8% from the 52-week high of $147.25. His non-derivative holdings fell from 15,058 to 5,058 shares, but his overall position remains significant at 61,700 shares via employee stock options (28,000 and 33,700 shares across two separate options). EchoStar faces headwinds: the company posted a net loss of $-146,885,000.00 over its most recent full fiscal year, with annual revenue declining -5.2% year-over-year and current quarterly revenue at $3,667,489,000.00. The scheduled nature of this trade removes discretionary timing considerations; investors should focus on the company's operational context—unprofitability and revenue contraction—rather than interpreting the sale as a timed market signal.

CLO Dean Manson sells 10,000 SATS shares at $119.50 under pre-arranged 10b5-1 plan; retains 5,058 shares plus 32,000 options

Dean Manson, Chief Legal Officer, completed a scheduled sale of 10,000 shares of EchoStar (SATS) at $119.50 on 2026-06-04 under a pre-arranged 10b5-1 trading plan adopted 2026-03-05. This is a non-discretionary, scheduled transaction; the stock has declined 8.3% over the prior 30 days and trades -20.8% below its 52-week high of $147.25. The company faces headwinds: it generated -$146.9M net income in the latest quarter, annual revenue contracted 5.2% year-over-year, and the company remains unprofitable on a full-year basis. Manson's prior trades at SATS show mixed near-term outcomes (ranging from -17.9% to +12.4% over 30 days), though his cross-ticker record averaged +36.9% over 90 days post-sale. Because this transaction is scheduled under a 10b5-1 plan rather than discretionary, it does not convey timing judgment. Manson retains 5,058 non-derivative shares and 32,000 employee stock options, preserving material equity exposure.

CLO Manson Dean sold 19,031 shares at $114.56 average price, reducing holdings by 79.2%, while company remains unprofitable with -5.2% annual revenue growth.

Manson Dean, Chief Legal Officer, executed 2 separate sales totaling 19,031 shares for $2,180,265.81, reducing his stake from 24,029 shares to 4,998 shares. The magnitude of the reduction (79.2% of prior holdings) is substantial for an executive officer whose residual position is now relatively modest at 5.0K shares. EchoStar operates in fundamentally challenged territory: net income was $-12,781,196,000.00 for the most recent full fiscal year, annual revenue contracted 5.2% year-over-year, and the company trades at a market cap of $5,241,759,326.88. The current price of $109.92 is down 16.2% from the 52-week high, suggesting recent depreciation from the sale prices ($114.51–$114.60). Dean's prior same-ticker history shows 2 prior sells that were not well-timed at the 90-day mark (posting positive subsequent returns of +8.6% and +127.8%), indicating his historical sales have not preceded declines at this ticker.

EchoStar CLO Dean sold 60,000 shares ($4.9M) on 2025-09-09 at $81.24, reducing holdings 96.3%; company unprofitable with -7.0% revenue growth.

Manson Dean, Chief Legal Officer, executed a substantial sale of 60,000 shares (96.3% of his holdings) for $4,874,400.00 at $81.24, leaving only 2,322 shares post-transaction. The transaction occurred at $81.24, which was -7.8% from the 52-week high of $83.57. EchoStar is operating unprofitably with a net income of $-306,844,000.00 and annual revenue decline of -7.0%, creating a fundamental backdrop of deteriorating operational performance. Dean's prior open-market sell at this same ticker (2025-07-09) resulted in a 30-day return of -17.9%, establishing a pattern of selling into declining periods; the current sale at near-52-week highs may similarly precede weakness, though this single prior SATS transaction provides limited predictive power for timing assessment.

CLO Manson Dean sold 25,000 SATS shares ($825.0K) at $33.00; reduced stake 91.5% to 2.3K shares post-sale

Manson Dean, Chief Legal Officer of EchoStar CORP, executed a substantial sale of 25,000 shares at $33.00 on 2025-07-09, reducing his holdings by 91.5% from 27.3K to 2.3K shares. This near-complete divestment occurs in a company with negative full-year net income and declining annual revenue (-7.0%), while the stock has appreciated 78.7% over the past 30 days and 37.3% over 90 days, suggesting the sale coincided with strong recent momentum. The transaction price of $33.00 was approximately 6.9% above the current price of $30.86, positioning the sale at the upper end of recent trading levels. A material reduction in holdings by an executive typically merits investor attention, particularly given the underlying operational headwinds reflected in the company's unprofitable status.